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Abstract
Background: Malaysia still faces challenges optimizing resources to effectively eliminate measles through high
immunization and herd immunity, with sporadic outbreaks of measles as evidence. The objective of this study is to
determine the age-specific positive measles antibodies seroprevalence used for assessing the establishment of herd
immunity against measles in different age groups. This is useful for identifying vulnerable age groups requiring
supplementary immunization.
Methods: A seroprevalence study was conducted among respondents aged 6–9 years, 15–24 years and 45–54
years attending government health clinics in Seremban between September 2014 and January 2015. A total of
1541 measles IgG antibody status were determined using ELISA technique (NovaTec Immundiagnostica GMBH)
and assessment of establishment of herd immunity was based on indicators developed by Plans. Data on
socio-demographic background as well as medical and medication history were also gathered.
Results: Seropositive rate for all respondents were 87% (95% CI 85–89), while the rest had either indeterminate
[6% (95% CI 5–7)] or negative titre [7% (95% CI 6–8)]. None of the factors analyzed except for age were significant
predictors of positive measles antibodies. Seropositive rate differed by age with the highest rate seen in adults (94%;
CI 92–96), followed by children (90%; 95% CI 87–94) and adolescents, and young adults (74%; 95% CI 70–78). Based on
Plans’ indicators, herd immunity was established in adults and children, but not in adolescents and young adults.
Conclusions: To tackle the most susceptible group in the present study, it is advisable to give booster vaccination to
secondary school students and freshmen who enter colleges and universities in Malaysia.
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Background
Measles is a highly contagious disease affecting more
than 95% of exposed populations before the introduction
of measles containing vaccine (MCV). In 1980, almost
2.6 million children aged below 6 years were estimated
dead secondary to measles annually [1]. Despite all the
progress in measles control, many countries are still
facing difficulties managing resources to protect their
children from this disease burden effectively. Therefore,
measles continues to be a leading cause of vaccine pre-
ventable mortality among children [2].
Malaysia was reported to be the country in the Western
Pacific Region with the highest confirmed measles inci-
dence with a rate of 63.7 per 1,000 000 populations in
2012 [3]. In Seremban, the incidence was higher with a
rate of 72.1 per 1,000 000 populations. Since 1982 until
2002, a single dose measles vaccination was given to
children at 9 months of age. Subsequently in 2002, the
Malaysian Ministry of Health implemented measles elim-
ination strategy when a double dose measles-mumps-
rubella (MMR) vaccine was introduced to children at
12 months and 7 years old [4].
Vaccination limits the number of secondary persons
who can be infected. Hence, we need to reduce the
number of unimmuned person so that outbreaks could
not occur [5]. The ultimate aim of the use of vaccination
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in infectious diseases field is disease elimination where
persistent transmission no longer exists in the popula-
tion and secondary infection due to imported cases is
terminated [6]. In order to assess immunization pro-
grammes for measles, it is beneficial if the level of anti-
body against measles is determined. Elimination of
indigenous measles could be obtained if the prevalence
of susceptible individuals remains at low level [7].
Study objectives
The main objectives of this study were to evaluate the
establishment of herd immunity against measles among
subgroups of population by comparing their seropreva-
lence of positive measles antibodies (p) with critical
prevalence of antibody associated with herd immunity
(pc) according to Plans [8].
Methods
Sampling population
This was an institutional ethics approved cross-sectional
study conducted among children, adolescents and young
adults, and adults attending government/ public health
clinics in Seremban, the capital of the state of Negeri
Sembilan from September 2014 to January 2015.
Seremban was chosen as s study site since the inci-
dence rate was high. It is also the biggest district in
Negeri Sembilan with the highest population having
both urban and rural health clinics. The sample size
calculation for this study was based on comparison of
two proportions [9] with power set at 80%, two-sided
confidence level at 95% and using the comparative
prevalence of a local study conducted by Saraswathy et al.
[10]. The sampling of patients was done using multistage
sampling. In the first stage, 10 of the 11 health clinics in
the district of Seremban were selected using non-
probability purposive sampling technique. In the second
stage, samples were stratified into three age groups; chil-
dren (6–9 years old), adolescents and young adults (15–24
years old), and adults (45–54 years old) similar to the age
group of the study conducted by Plans [8]. Every 5th
patient attending the selected health clinics were recruited
into the study according to the stratified age.
About 5 mls of blood sample were collected in a plain
tube, followed by extraction of 1 mls of serum which was
kept deep frozen between -20° and -70 °C until analysed.
Other factors like socio-demographic background as well
as medical and medication history were collected through
face to face interview with respondents/ parents or
guardians using a standardized and validated question-
naire. The measles IgG antibody status were determined
using ELISA (Enzyme-linked Immunosorbent Assay)
technique (NovaTec Immunodiagnostica GMBH) [11] at
the accredited Pathology Laboratory, Hospital Tuanku
Jaafar. According to the manufacturer’s information, the
sensitivity and the specificity of the measles IgG kit were
more than 95% [11].
Data analysis
The serological findings were classified as seronegative
when measles IgG level was less than 120 IU/ml, indeter-
minate when the measles IgG level was between 120 and
220 IU/ml and seropositive when measles IgG level was
more than 220 IU/ml. For statistical analysis, the respon-
dents were classified into those who were seropositive and
those who were not (indeterminate and seronegative).
Descriptive and analytical analyses of data were carried
out using ‘Statistical Package for Social Sciences’ (SPSS)
Version 20.0. Statistical significance level was taken at
the p value < 0.05 and 95% confidence intervals (CI).
Descriptive statistics such as frequency and percentage
were used to analyse the socio-demographic variables.
The binary logistic regression analysis was used to deter-
mine the association between the variable of interest and
positive measles antibody in the respondents. If signifi-
cant association between variables were found, the Odds
Ratio value will be used to determine the association
between the variable in question and positive measles
antibody.
Finally, the establishment of herd immunity was deter-
mined based on Plans’ indicator [8]. Herd immunity was
established when the prevalence of antibodies observed
in a serological study (p) was higher than the critical
prevalence of antibodies associated with herd immunity
(pc); p > pc.. Herd immunity was not established when
the prevalence of antibodies observed in a serological
study (p) was lower than the critical prevalence of anti-
bodies associated with herd immunity (pc); p < pc, where
p was the positive seroprevalence of measles IgG and pc,
the critical prevalence of antibody against measles was de-
termined using a mathematical model developed by Plans
[8]. In Plans’ formula, p was also used to estimate the crit-
ical prevalence of antibody against measles (pc) in the
population and by subgroups (age, gender and ethnicity)
as shown in the formulae.
Seroprevalence of positive measles antibody (p)
The variable (p) denoted the presence of antibody against
measles (positive measles IgG) in the study population.
The prevalence (p), is also used to calculate PPV, a
component for the estimation of critical prevalence of
antibodies associated with herd immunity (pc) as shown in
Formula 1.
Critical prevalence of antibodies associated with herd
immunity (pc)
The estimation of critical prevalence of antibodies asso-
ciated with herd immunity (pc) was based on Formula 1.
The critical prevalence of antibodies associated with
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herd immunity (pc) could be determined from the preva-
lence of protected individuals or herd immunity thresh-
old (Ic), the sensitivity (Se) and predictive value of
positive serological result (PPV) [8]:
pc ¼ IcSe = PPV Formula 1ð Þ
where;
Ic = Herd immunity threshold equals 92.5% based on
Plans’ indicator [8]
Se = Sensitivity of the serological test equals more than
95% based on manufacturer’s data
PPV = Predictive value of positive serological result
Herd immunity threshold (Ic)
Herd immunity threshold (Ic) was defined as the mini-
mum prevalence of individuals who are protected neces-
sary to cease the transmission of an infection in the
population [12, 13].
Ic ¼ Ro 1= Ro ¼ 1  1= Ro ðFormula 2Þ
Ic is 91-94%, of which the mean was 92.5% based on
Plans [8] with Ro, basic reproductive number for measles
of 11 – 18.
Sensitivity of the serological test (Se)
This was more than 95% according to manufacturer’s
data [10].
Predictive value of positive serologic result (PPV)
In this formula, the predictive value of positive serologic
result could be obtained from the prevalence of anti-
bodies (p), the sensitivity (Se) and the specificity (Sp) of
the serologic test:
PPV ¼ pSeð Þ= pSeð Þ þ 1−pð Þ 1−Spð Þ½  Formula 3ð Þ
Results and discussion
Results
Socio-demographic characteristics and medical/ medication
history of participants
A total of 1541 of the 1712 (90%) patients approached
agreed to participate in this study. Table 1 shows that
most of the respondents were adults aged 45–54 years
(48.9%), followed by adolescents and young adults aged
15–24 years (31.7%) and children aged 6–9 years (19.3%).
The numbers of female participants were slightly higher
(53.2%) than male participants (46.8%). A total of 927
(60.2%) participants were Malays, 74.2% had lower educa-
tion and 75.1% had lower household income. Lower
educational level was defined as those who did not go to
school or had received at most secondary education
whereas lower household income was defined as average
total income for all household members in Malaysian
Ringgit (MYR) of less than RM 4000 for a typical month.
The respondents were mostly born in places outside
Seremban (54.4%) and in urban locality (66%). Of all re-
spondents, 81.6% attended urban located health clinics in
Seremban district and most of them had no medical prob-
lems (61.1%) and were not on any medications (63.3%).
Seroprevalence and associated factors of measles
antibodies (measles IgG)
Table 1 also shows the percentages of respondents who
were measles IgG seropositive, indeterminate or sero-
negative by different socio-demographic variables and
medical/ medication history. The overall prevalence of
positive titre for measles IgG in the sample surveyed was
87% (95% CI 85-89) while 6% (95% CI 5-7) of all respon-
dents had indeterminate titre and another 7% (95% CI
6-8) had negative titre. The proportion of seropositive
respondents differed by age and was highest in adults
aged 45–54 years (94%; 95% CI 92-96) and lowest in
teenagers and young adults aged 15–24 years (74%; 95%
CI 70-78). The proportion of respondents with indeter-
minate and negative titre level was highest in teenagers
and young adults aged 15–24 years (11%; 95% CI 9-14
and 15%; 95% CI 11-18) and lowest in adults aged 45–
54 years (3%; 95% CI 2-4).
Differences in measles seropositive rate were seen by
gender and ethnicity. Female respondents had higher
positive titre (88%; 95% CI 86-91) in comparison to male
respondents (85%; 95% CI 83-88). Measles seropositive
rate was lowest in Malays (86%; 95% CI 83-88) and was
highest in others (93%; 95% CI 83-103). Both Chinese
and Indian had measles seropositive rate of 90% (95% CI
85-94) and 89% (95% CI 85-92) respectively. Differences
were also seen by education level with respondents with
lower education level having higher positive titre (88%;
95% CI 87-90), while those with higher education level
had lower positive titre (83%; 95% CI 79-87).
Positive seroprevalence was also higher in respondents
with higher household income (89%; 95% CI 86-92),
born outside Seremban (89%; 95% CI 87-91) and rural
born (89%; 86-92). Measles seropositive rate was slightly
lower in respondents who attended rural health clinics
(86%; 95% CI 81-91) in comparison to respondents who
attended urban health clinics (87%; 95% CI 86-89). Obvi-
ous differences were also found in respondents with
medical problems and medication history where both
had higher positive titre for measles IgG (92%; 95% CI
90-94 and 93%; 95% CI 90-95).
The possible association between socio-demographic
variables and medical/ medication history and preva-
lence of measles antibodies was analysed by initially con-
ducting chi square test and further verified with simple
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logistic regressions. Simple logistic regression tests were
conducted to screen for important independent variables
prior to multivariable analysis. To test for the association
of these socio-demographic and medical/ medication
history, measles seropositive titre were compared.
Table 1 shows that there were significant differences in
measles positive seroprevalence by age, education level,
place of birth, medical problems and medication history (p
< 0.05). Adolescents and young adults aged 15–24 years
had decreased Odds of having positive measles IgG by 69%
compared to children aged 6–9 years (OR 0.31; 95% CI
0.20-0.47) while adults aged 45–54 years had Odds ratio of
1.74 (95% CI 1.07-2.84) of having positive measles IgG in
comparison to children aged 6–9 years.
Respondents with higher education level had decreased
Odds of having positive measles IgG titre by 35% in com-
parison to those with lower education level (OR 0.65; 95%
CI 0.47-0.89). Those born in Seremban had decreased
Table 1 Association between socio-demographic characteristics and medical/ medication history and seroprevalence of measles
antibodies (measles IgG titre), (n = 1541)
Characteristics Seroprevalence of measles IgG titre
N(%) Positive titrea (95% CI) Indeterminate and negative titresb (95% CI) Crude odds ratio (95% CI) p value
Total 1541(100) 87% (85–89) 13% (11–15)
Age (year)
[6–9] 298 (19.3) 90% (87–94) 10% (6–13) 1.00
15–24 489 (31.7) 74% (70–78) 26% (22–30) 0.31 (0.20 – 0.47) 0.0001
45–54 754 (48.9) 94% (92–96) 6% (4–8) 1.74 (1.07 – 2.84) 0.027
Gender
[Male] 721 (46.8) 85% (83–88) 15% (12–17) 1.00
Female 820 (53.2) 88% (86–91) 12% (9–14) 1.30 (0.97 – 1.75) 0.083
Ethnicity
[Non-Malay] 614 (39.8) 89% (87–92) 11% (8–13) 1.00
Malay 927 (60.2) 86% (83–88) 14% (12–17) 0.73 (0.54–1.00) 0.050
Education Level
[Lower] 1144 (74.2) 88% (87–90) 12% (10–13) 1.00
Higher 397 (25.8) 83% (79–87) 17% (13–21) 0.65 (0.47–0.89) 0.008
Household income
[Lower] 1157 (75.1) 86% (84–88) 14% (12–16) 1.00
Higher 384 (24.9) 89% (86–92) 11% (8–14) 1.29 (0.90–1.85) 0.170
Place of birth
[Others] 839 (54.4) 89% (87–91) 11% (9–13) 1.00
Seremban 702 (45.6) 85% (82–88) 15% (12–18) 0.71 (0.53–0.96) 0.024
Locality of place of birth
[Urban] 1017 (66.0) 86% (84–88) 14% (12–16) 1.00
Rural 524 (34.0) 89% (86–92) 11% (8–14) 1.30 (0.94–1.81) 0.110
Locality of health clinics attended
[Urban] 1258 (81.6) 87% (86–89) 13% (11–14) 1.00
Rural 283 (18.4) 86% (81–90) 14% (10–19) 0.85 (0.59–1.24) 0.404
Medical problems
[No] 941 (61.1) 84% (81–86) 16% (14–19) 1.00
Yes 600 (38.9) 92% (90–94) 8% (6–10) 2.22 (1.57–3.12) 0.0001
Medication history
[No] 976 (63.3) 84% (81–86) 16% (14–19) 1.00
Yes 565 (36.7) 93% (90–95) 7% (5–10) 2.41 (1.68–3.43) 0.0001
[] Reference group
aPositive titre: > 220 IU/ml
bIndeterminate titre 120–220 IU/ml and negative titre < 120 IU/ml
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Odds to be seropositive by 29% than those who were born
outside (OR 0.71; 95% CI 0.53-0.96). Those with medical
problems had Odds ratio of measles seropositive of 2.22
(95% CI 1.57-3.12) in comparison to those who gave no
history of medical problems. Respondents with history of
taking medications were also more likely to be seroposi-
tive than those who were not (OR 2.41; 95% CI 1.68-3.43).
For multivariable or adjusted analysis, after adjusting
for significant variables explored in the crude analysis,
only age group remained the strongest and significant
predictor for seropositivity of measles IgG based on both
forward selection and backward elimination strategies.
Establishment of herd immunity against measles among
all respondents
Herd immunity is established when p > pc. In the subse-
quent analysis, Table 2 shows three scenarios depending
on how we dealt with the 6% indeterminate titre out-
come of the 1541 respondents in the study.
In the first case, considered as the worst case scenario,
analysis of 1541 respondents and assuming all 94 indeter-
minate cases as seronegative gave us a p, seropositive rate
of 87% and the calculated pc based on Plans’ indicator was
89.4%. Thus p < pc and herd immunity for the 1541 re-
spondents was not established. Subsequent assessment of
subgroups, the 15–24 years old respondents, both genders,
in Malays and Indians also revealed that herd immunity
were not established since p < pc. However, herd immunity
was established among the 6–9 years old, 45–54 years old,
and among Chinese and others since p > pc.
In the second scenario, considered the best case, ana-
lysing all 1541 respondents and assuming all 94 indeter-
minate measles IgG cases as positive, gave us a measles
seropositive rate, p of 93%, while the calculated pc based
on Plans’ indicator was 89.1%. Hence, p > pc and herd
immunity for the 1541 respondents was established in
the best case scenario. Subsequent assessment showed
that the 6–9 and 45–54 years old, both genders and all
ethnicities showed establishment of herd immunity since
p > pc. Nevertheless, among the 15–24 years old, herd
immunity was not established since p < pc.
In the final scenario, using only absolute cases, those
with known positive and negative measles IgG titre (n =
1447), gave us a p, seropositive rate of 93%, and the
calculated pc based on Plans’ indicator of 89.1%. Herd
immunity for the 1447 absolute cases was established
since p > pc. Subsequent analysis by age, gender and
ethnic subgroups revealed similar findings as in the best
case scenario when p was also 93%.
Discussion
The positive seroprevalence of measles IgG antibodies in
Seremban was 87%. This is higher compared to a previ-
ous Malaysian study by Saraswathy et al. [10] where in-
dividuals aged more than 7 years had prevalence rate of
82.8%. A study conducted among healthy individuals in
Baoji City, Shaanxi Province, China demonstrated the
Table 2 Seroprevalence of positive measles antibodies (p), critical prevalence of antibodies associated with herd immunity (pc) and
establishment of herd immunity (HI) - comparing worst, best and absolute case scenario
Characteristics Establishment of herd immunity (HI)
Worst Casea (n = 1541) Best Caseb (n = 1541) Absolute Casec (n = 1447)
p (%) (95% CI) pc (%) (range) HI p (%) (95% CI) pc (%) (range) HI p (%) (95% CI) pc (%) (range) HI
Total 87.0 (85.0–89.0) 89.4 (87.9–90.8) - 93.0 (92.0–94.0) 89.1 (87.6–0.5) + 93.0 (91.0–94.0) 89.1 (87.6–90.5) +
Age (year)
6–9 90.0 (87.0–94.0) 89.2 (87.4–90.7) + 95.0 (92.0–97.0) 89.0 (87.6–90.5) + 95.0 (92.0–97.0) 89.0 (87.6–90.5) +
15 – 24 74.0 (70–78) 90.4 (88.9–91.8) - 85.0 (82.0–89.0) 89.5 (88.0–90.9) - 84.0 (80.0–87.0) 89.5 (87.6–90.5) -
45–54 94.0 (92.0–96.0) 89.0 (87.6–90.5) + 97.0 (96.0 – 98.0) 88.9 (87.5–90.4) + 97.0 (96.0–98.0) 88.9 (87.5–90.4) +
Gender
Male 85.0 (83.0–88.0) 89.5 (88.0–90.9) - 92.0 (90.0–94.0) 89.1 (87.7–90.6) + 92.0 (89.0–94.0) 89.1 (87.7–90.6) +
Female 88.0 (86.0–91.0) 89.3 (87.9–90.7) - 94.0 (92.0–96.0) 89.0 (87.6–90.5) + 94.0 (92.0–95.0) 89.0 (87.6–90.5) +
Ethnicity
Malay 86.0 (83.0–88.0) 89.4 (87.9–90.8) - 92.0 (91.0–94.0) 89.1 (87.7–90.6) + 92.0 (90.0–94.0) 89.1 (87.7–90.6) +
Chinese 90.0 (85.0–94.0) 89.2 (87.8–90.7) + 93.0 (90.0–97.0) 89.1 (87.6–90.5) + 93.0 (90.0–97.0) 89.1 (87.6–90.5) +
Indian 89.0 (85.0–92.0) 89.3 (87.8–90.7) - 94.0 (92.0–97.0) 89.0 (87.6–90.5) + 94.0 (92.0–97.0) 89.0 (87.6–90.5) +
Others 93.0 (83.0–103.0) 89.1 (87.6–90.5) + 96.0 (89.0–104.0) 88.8 (87.4–90.4) + 96.0 (89.0–104.0) 88.8 (87.4–90.4) +
aAssuming all indeterminate results are negative,b Assuming all indeterminate results are positive, cIneterminate result are not presented
(p) Seroprevalence of positive measles antibodies; (pc) Critical prevalence of antibodies associated with herd immunity
(HI) Herd Immunity; + Herd Immunity Established (p >mean pc); - Herd Immunity Not Established (p <mean pc)
Calcualted using Critical Prevalence of Protected Individuals, Ic (%) = 92.5 (91–94)
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overall measles antibodies positive rate of 78.9% [14].
However, the seropositive rate was lower when com-
pared to a study conducted in Catalonia, Spain where
the global measles antibodies was 98.3% [7]. Contrary
to this study, the study in Catalonia, Spain was con-
ducted as a population based study which represents
the whole community. In our study, the respondents
were limited to those who attended government or
public health clinics.
Factors that were explored among all respondents in
this study included socio-demographic characteristics
such as age, gender, ethnicity, education level, household
income, place of birth, and location of place of birth and
health clinics attended. Factors that may contribute to
failure of being immune or getting immunization such
as history of medical illness and medication history were
also investigated. In the multivariable analysis, after
adjusting for all explored confounders, we found only age
group remained the significant predictors for measles anti-
bodies in this study.
The seroprevalence of measles antibodies found in chil-
dren (90%) was slightly lower than adults group (94%) but
much higher than in the adolescents and young adults
group (74%). Comparing to children aged 6–9 years in this
study, adolescents and young adults group had OR of 0.31
and adults group had increased OR of 1.74 to have posi-
tive measles antibodies. Similar findings were elicited in a
study conducted in Catalonia, Spain [8] and Israel [15].
However, the prevalence rate for measles antibodies in
those studies among adolescents and young adults were
higher (83.8% and 85.7% respectively) than that found in
this study. The difference in these findings may be due to
the supplementary immunization activities (SIA) that were
carried out in Catalonia in 1998 and 1999 for the cohorts
born in 1988–1999.
Furthermore, the low prevalence rate of positive
measles antibodies and high prevalence rate of inde-
terminate in teenagers and young adults aged 15–24
years in this study may be due to primary or secondary
vaccine failure.
Primary vaccine failure or failure to seroconvert could
happened among adolescents and young adults in
Malaysia as their birth cohort received immunization at a
very young age which was at 9 months old. Leuridan et al.
[16] explained that vaccination at an earlier age is not ad-
visable because of immature human responses of infants.
Secondary vaccine failure or waning immunity could be
another reason for the decline of measles antibodies in
both children and adolescents and young adults groups as
compared to adults group. Vaccine recipients would be
most likely to develop this type of vaccine failure because
those who are vaccinated have lower measles-specific
antibody as compared to those who experienced natural
measles infection. In addition, the decline in measles
antibodies is more rapid in those who are vaccinated than
those who recuperate from measles infection [17]. The
finding of this current study did not differ from a pro-
spective cohort study by LeBaron et al. which revealed a
progressive decline in measles antibodies 10 years after a
second dose of measles vaccine [18]. This could explained
why adolescents and young adults aged 15–24 years in
this study had lower prevalence rate of measles antibodies
than children 6–9 years old.
The current study showed there were no significant
differences between genders in term of measles anti-
bodies level. This result was in line with seroprevalence
surveys conducted by Levine et al. [15], Sultana et al.
[19], Yekta et al. [20], Davidkin et al. [21] and Onoja &
Adeniji [22] but differ from a study by Poethko-Muller
& Mankertz [23] which found boys had higher levels of
susceptibility than girls. Aaby et al. [24] also found that
there were sex differences in measles vaccine efficacy in
their study.
Several epidemiological studies have identified ethni-
city as one of the factors that prevented certain groups
of people from being vaccinated and resulted in low
prevalence of measles antibodies [25–27]. A study by
Mixer et al. [28] revealed different ethnicity with differ-
ent cultural background is an important predictor for
the uptake of MMR vaccine. White mothers staying in
an underprivileged area were not keen to get their child
immunized [29]. McQuillan et al. [30] demonstrated that
non-Hispanic whites and Mexican Americans were the
most susceptible group for measles infection in the United
States population. Contrary to those findings, this study
did not show any significant association between ethnicity
and seropositive measles antibodies.
Respondents with lower education were found to have
higher seropositive rate than those with higher education
from the initial crude analysis. However, multivariate
analysis revealed there was no association between level
of education and positive measles antibodies. A sero-
prevalence study by Levine et al. [15] also showed simi-
lar findings but McQuillan et al. [30] found that higher
education was a predictor of seropositive measles
antibodies.
In the current study, total household income among
respondents either lower or higher had no significant
association with seropositive measles antibodies. The
finding was similar to the study conducted by Sultana et
al. [19] where the association between prevalence of
measles antibodies and socio-economic classes was not
significant. In contrast with this finding, in the Catalo-
nian study, seropositive measles antibodies were higher
among the rich compared to the poor [7]. Another study
by Mixer et al. [28] also showed that higher MMR
vaccination coverage was significantly associated with
higher socioeconomic status.
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McQuillan et al. [30] concluded in their study that
place of birth outside of the United States was a pre-
dictor for positive measles antibodies. United States-
born Mexican Americans had higher seropositivity for
measles antibodies than foreign-born Mexican Americans.
Senn et al. [31] demonstrated in the study conducted in
Papua New Guinea that urban population were more
susceptible to get measles infection as compared to rural
population. Foreign-born children in Germany also had a
higher risk of susceptibility against measles [32]. However,
the present study did not find any association between
positive measles antibodies titre and place of birth (either
in or outside Seremban) or rural or urban locality of birth.
The location of health clinics attended was also not a
significant factor for development of measles antibodies in
this study. Onoja & Adeniji [22] also found non-
significant difference between the mean measles titre
in two locations of health centres in Nigeria.
There were no demonstrated differences between
juvenile idiopathic arthritis patients and healthy indi-
viduals in term of measles antibodies concentration
and seroprotective rates [33]. The finding was similar
with the present study in which medical problems and
medication history were not significant predictors for
seropositive measles antibodies. Nevertheless, seropositiv-
ity can be expected in the majority of vaccine recipients
with DiGeorge Syndrome, post-bone marrow or solid
organ transplantation and in HIV-positive children with
no severe immune defects [34]. High levels of measles
antibodies were also documented in psychiatric patients
on treatment compared to non-psychiatric individuals
[35]. Prospective cohort study should be considered in
investigating contributing factors for elevated measles
antibodies in such groups.
Establishment of herd immunity against measles among
all respondents
Plans [8] developed a new indicator to assist in deter-
mining the accepted level of herd immunity in a popula-
tion. The new indicator which is the critical prevalence
of antibodies associated with herd immunity (pc) has
enabled a population to be evaluated for the establish-
ment of herd immunity. This indicator was derived from
the prevalence of positive measles antibodies (p) obtained
in a seroprevalence study. Taken into consideration is the
value of basic reproductive number, Ro which varies
according to population density. A higher value of Ro and
pc is expected in a dense population [8].
In this study, herd immunity was not established in
analysis of the total study population (n = 1541). Herd
immunity against measles was established in children,
adults, Chinese and others (other than Malay, Indian
and Chinese ethnicity) but not in adolescents and young
adults, both genders, and among Malays and Indians.
Based on multivariable analysis, age group was the only
predictor for positive measles antibodies in this study.
Thus, it is worth planning an immunization program
focusing on the susceptible age group which is the ado-
lescents and young adults. Future outbreaks are fore-
casted imagining these groups of individuals reaching
adulthood. Similar findings were reported in many of
the previous measles outbreaks in Malaysia [36]. The
adolescents and young adults group can be considered a
homogenous population because many remain in second-
ary schools, colleges and universities. Supplementary
immunization activities (SIA) can be concentrated among
secondary school students and freshmen in universities.
The three different age groups in this study came from
various birth cohorts experiencing different immunization
programs or strategies implemented in the country as
shown in Table 3. From the table, we hypothesize that
adults aged 45–54 years developed their immunity sec-
ondary to natural infection. Vaccination was lacking and
wide circulation of measles virus in the 1960s had ended
in a near-universal measles exposure and enhanced the
establishment of natural immunity. On the other hand,
children, adolescents and young adults groups developed
their immunity most probably via vaccination. The low
prevalence rate of positive measles antibodies and high
prevalence rate of indeterminate in teenagers and young
adults aged 15–24 years may be attributable to different
vaccination strategies during childhood.
The three scenarios with different assumptions made
for indeterminate serological status in Table 2 can be eye
opening for health managers and policy makers to
strengthen the measles control strategies in Malaysia.
Taking into account the best case scenario, where all
indeterminate cases were considered seropositive, the
establishment of herd immunity against measles is seen
in the whole population, in children and adults group, in
both gender and in all ethnic groups but not among
Table 3 Malaysian immunization program by birth cohort
Age group
(years)
Birth cohort Immunization program in Malaysia
45–54 Born in
1960–1969
• No measles vaccination program in Malaysia
15–24 Born in
1990–1999
• Single dose measles vaccination was given
to children at 9 months old
• Malaysia mass immunization campaign or
catch-up campaign in 2004 in which another
booster dose of single measles vaccine was
given to all school children aged 7–15 years
old (Birth cohort 1990–1997 in this study
were involved)
• Children who were born in 1998–1999
received second dose of MMR vaccine when
they were in standard one
6–9 Born in
2006–2009
• Received two doses MMR vaccine; once at
12 months and the second at 7 years of age
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adolescents and young adults. It has been a decade since
the last catch-up campaign for measles which was in
2004. Again, catch-up campaigns need to be imple-
mented in Malaysia in order to block the transmission
of the measles virus.
With this finding, policy makers and health managers
can plan new immunization strategies for Seremban
district that should include catch-up campaigns. The
result of this study may be generalized to populations
with similar background as ours. Studies on the cost
effectiveness of different immunization strategies such as
vaccination of adults, catch-up vaccination and different
timing of vaccination should be conducted to help in
evidence-based decision making. Several study limita-
tions were identified and these include selection and
measurement or information bias. The study is limited to
clients who attended public or government health clinics.
A population based study similar to the samples in the
Malaysian National Health Morbidity Surveys (NHMS)
would be more representative and generalizable. Response
bias should be considered as those who agreed to partici-
pate in this study may in some ways be different from
those who refused to participate. However, this type of
bias had been minimised due to our high response rate.
Conclusions
In order to achieve control over measles, it is crucial to
implement evidence-based vaccination policy. This study
recognized adolescents and young adults as pocket of
susceptibles. In future, supplementary immunization ac-
tivities (SIAs) in Malaysia should focus on adolescents
and young adults. Seroprevalence study should be car-
ried out at regular interval to monitor measles anti-
bodies in different birth cohorts in order to identify to
whom intervention strategies should be prioritized. This
will eventually provide better measles control and ultim-
ately measles elimination in Malaysia.
Abbreviations
CI: Confidence interval; ELISA: Enzyme-linked immunosorbent assay;
HIV: Human Immunodeficiency Virus; IgG: Immunoglobulin G; MCV: Measles
containing vaccine; MMR: Measles-mumps-rubella; NHMS: National Health
Morbidity Surveys; OR: Odds ratio; PPV: Positive predictive value of
serological test; SIAs: Supplementary immunization activities; SPSS: Statistical
Package for Service Solutions; UKMMC: Universiti Kebangsaan Malaysia
Medical Centre
Acknowledgements
We sincerely acknowledged all who had participated in the data collection.
Special appreciation and thanks to the Director General of Health Malaysia,
Datuk Dr. Noor Hisham bin Abdullah, the Deputy Director of Health (Public
Health) at Department of Health, Negeri Sembilan, Dr. Zainudin bin Mohd
Ali, Seremban District Health Officer, Dr. Paid bin Yusof, Family Medicine
Specialists, Medical Officer In Charge and all the staff in health clinics under
Seremban District Health Office, Head of Pathology Department, Dr. Azizon
Othman and all the staff in the Microbiology Department, Hospital Tuanku
Jaafar, Seremban, for their time and contribution with the data collection.
Funding
This work was supported by the Universiti Kebangsaan Malaysia Medical
Centre (FF-2014-163).
Availability of data and materials
The data that support the findings of this study are available from
[UKMMC and Ministry of Health, Malaysia] but restrictions apply to the
availability of these data, which were used under license for the current
study, and so are not publicly available. Data are however available from
the authors upon reasonable request and with permission of
[UKMMC and Ministry of Health, Malaysia].
Authors’ contributions
HY, MMA & KS contributed to the design, analysis and write up
of this study. HY produced the first draft of the manuscript.
All authors contributed to the revision of the draft. The final
manuscript has been read and approved by all authors.
Competing interests
The authors declared that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Ethics approval (FF-2014-163) for this study was obtained from the
Universiti Kebangsaan Malaysia Medical Centre (UKMMC), Malaysia and
the Medical Research and Ethics Committee (MREC), Ministry of Health,
Malaysia (NMRR-13–1289-18795). Specifically for children, assents together
with parental or guardian agreement were obtained. Informed consent was
taken from the respondents and parents or guardian of those aged under 18.
Author details
1Department of Community Health, Faculty of Medicine, Universiti
Kebangsaan Malaysia Medical Centre (UKMMC), Jalan Yaacob Latiff, Bandar
Tun Razak, Cheras, 56000 Kuala Lumpur, Malaysia. 2Department of Pathology,
Hospital Tuanku Jaafar, Jalan Rasah, 70300 Seremban, Negeri Sembilan,
Malaysia.
Received: 5 April 2016 Accepted: 28 November 2016
References
1. Strebel PM, Cochi SL, Hoekstra E, Rota PA, Featherstone D, Bellini WJ, Katz
SL. A world without measles. J Infect Dis. 2011;204 Suppl 1:S1–3.
2. CDC. Progress in Global Measles Control and mortality reduction, 2000-
2007. Morb Mortal Wkly Rep. 2008;57:1303–6.
3. CDC. Progress toward Measles Elimination-Western Pacific Region, 2009-
2012. Morb Mortal Wkly Rep. 2013;62(22):443–7.
4. MOH. Measles Prevention and Control in Malaysia: Handbook for healthcare
personnel. Kuala Lumpur: Ministry of Health, Malaysia; 2006.
5. Hollingsworth TD. Controlling infectious disease outbreaks: Lessons from
mathematical modelling. J Public Health Policy. 2009;30(3):328–41.
6. De Serres G, Gay NJ, Farrington CP. Epidemiology of transmissible diseases
after elimination. Am J Epidemiol. 2000;151:1039–52.
7. Dominguez A, Plans P, Costa J, Torner N, Cardenosa N, Batalla J, et al.
Seroprevalence of measles, rubella, and mumps antibodies in Catalonia, Spain:
results of a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2006;25:310–7.
8. Plans P. Prevalence of antibodies associated with herd immunity: A new
indicator to evaluate the establishment of herd immunity and to decide
immunization strategies. Med Decis Mak. 2010;30:438–43.
9. Pocock SJ. Clinical Trials: A Practical Approach. Chichester: John Wiley and
Sons; 1983.
10. Saraswathy TS, Zahrin HN, Norshahmimi H, Az-Ulhusna A, Zainah S, Rohani
J. Impact of measles elimination strategy on measles incidence in Malaysia.
Southern Asian J Trop Med Public Health. 2009;40:742–7.
11. Novatech Immunodiagnostica GMSH. http://www.novatec-id.com/.
Accessed 20 August 2013.
12. Anderson RM. The concept of herd immunity and the design of
community-based immunization programmes. Vaccine. 1992;10(13):928–35.
Hazlina et al. BMC Infectious Diseases  (2016) 16:740 Page 8 of 9
13. Georgette N. The quantification of the effects of changes in population
parameters on the herd immunity threshold. Int J Epidemiol. 2007;5(1):5.
14. Zhang X, Kou G, Du H, Ju Z, Zhong L, Cui X, et al. Measles epidemiology
and survey of measles immunity level among healthy population in Baoji
City, Shaanxi Province, China. Jpn J Infect Dis. 2013;66(5):1884–2836.
15. Levine H, Zarka S, Ankol OE, Rozhavski V, Davidovitch N, Aboudy Y, et al.
Seroprevalence of measles, mumps and rubella among young adults, after
20 years of universal two-dose MMR vaccination in Israel. Human Vaccines
Immunother. 2015;11(6):1400–5.
16. Leuridan E, Sabbe M, Damme PPV. Measles outbreak in Europe: Susceptibility
of infants too young to be immunized. Vaccine. 2012;30(41):5905–13.
17. Markowitz LE, Preblud SR, Fine PE, Orenstein WA. Duration of live measles
vaccines-induced immunity. Pediatr Infect Dis J. 1990;9:101–10.
18. LeBaron CW, Beeler J, Sullivan BJ, Forghani B, Bi D, Beck C, Audet S,
Gargiullo P. Persistence of measles antibodies after 2 doses of measles
vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;
161(3):294–301.
19. Sultana R, Rahman MM, Hassan Z, Hassan MS. Prevalence of IgG antibody against
measles, mumps and rubella in Bangladeshi children: A pilot study to evaluate
the need for integrated vaccination strategy. Scand J Immunol. 2006;64:684–9.
20. Yekta Z, Porali R, Taravati MR, Salary S, Khalily F, Shahabi S. Measles IgG sero-
prevalence and its attributable factors in 5-25-year-old cases prior mass
vaccination campaign in Urmia, Northeastern Iran. Iranian Red Crescent
Med J. 2007;9(1):28–35.
21. Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of
measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-
year follow-up. J Infect Dis. 2008;197:950–6.
22. Onoja AB, Adeniji AJ. Kinetics of measles antibody by hemagglutination
inhibition assay in children in south-west and north-central Nigeria. Int J
Infect Dis. 2013;17(7):e552–5.
23. Poethko-Muller C, Mankertz A. Sero-epidemiology of measles specific IgG
antibodies and predictive factors for low or missing titres in a German
population-based cross sectional study in children and adolescents (KiGGS).
Vaccine. 2011;29(45):7949–59.
24. Aaby P, Martins C, Bale C, Garly ML, Rodrigues A, Biai S, Lisse IM, Whittle H,
Benn CS. Sex differences in the effect of vaccines on the risk of hospitalization
due to measles in Guinea-Bissau. Paediatr Infect Dis J. 2010;29(4):324–8.
25. Stein-Zamir C, Abramson N, Shoob H, Zentner G. An outbreak of measles in
an ultra-orthodox Jewish community in Jerusalem, Israel, 2007- an in-depth
report. Eurosurveillance. 2008;13:8045.
26. Lernout T, Kissling E, Hutse V, De Schrijver K, Top G. An outbreak of measles
in orthodox Jewish communities in Antwerp, Belgium, 2007–2008: different
reasons for accumulation of susceptibles. Eurosurveillance. 2009;14:19087.
27. Anis E, Grotto I, Moerman L. Measles in a highly vaccinated society: the
2007–08 outbreaks in Israel. J Infect. 2009;59:252–8.
28. Mixer RE, Jamrozik K, Newsom D. Ethnicity as a correlate of the uptake of
the first dose of mumps, measles and rubella vaccine. J Epidemiol
Community Health. 2007;61:797–801.
29. Baker D, Garrow A, Shiels C. Inequalities in immunisation and breast feeding
in an ethnically diverse urban area: cross-sectional study in Manchester, UK.
J Epidemiol Community Health. 2011;65:346–52.
30. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH.
Seroprevalence of measles antibody in the US population, 1999–2004. J
Infect Dis. 2007;196:1459–64.
31. Senn N, Riddell M, Omena M, Siba P, Reeder JC, Clements CJ, Morgan C.
Measles in Papua New Guinea: an age-specific serological survey. Vaccine.
2009;28(7):1819–23.
32. Poethko-Muller C, Mankertz A. Seroprevalence of measles-, mumps- and
rubella-specific igg antibodies in German children and adolescents and
predictors for seronegativity. PLoS ONE. 2012;7(8):e42867.
33. Heijstek MW, Gageldonk PGM, Berbers GAM, Wulffraat NM. Differences in
persistence of measles, mumps, rubella, diphtheria and tetanus antibodies
between children with rheumatic disease and healthy controls: a
retrospective cross-sectional study. Ann Rheum Dis. 2012;71:948–54.
34. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or
autoimmune diseases. Clin Infect Dis. 2008;46:1459–65.
35. Dickerson F, Stallings C, Origoni A, Copp C, Khushalani S, Yolken R.
Antibodies to measles in individuals with recent onset psychosis. Schizophr
Res. 2010;119(1-3):89–94.
36. Rosemawati A. Towards measles elimination – measles situation in Malaysia
before. Infect Dis Bull. 2003;2005:8–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Hazlina et al. BMC Infectious Diseases  (2016) 16:740 Page 9 of 9
